TXG
$69.86-3.50%
as of close, Oct 16, 2026
☾ AH $69.86 -3.50%
10x Genomics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.01%Russell 3000 0.006%US Stock Market 0.006%
TXG financial statements
The full income statement, balance sheet, and cash-flow statement for 10x Genomics Inc. (TXG), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 120.1M2024-09 120.7M2024-12 122.3M2025-03 122.6M2025-06 124.5M2025-09 125.5M2025-12 127.7M2026-03 128.3M2026-06 130.3M+8.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 643M+5.2% | 611M-1.3% | 619M+19.8% | 516M+5.3% | 490M+64.1% | |
| 444M+7.1% | 414M+1.3% | 409M+3.4% | 396M-4.9% | 416M+73.2% | ||
| Cost of revenue | 199M+1.3% | 196M-6.3% | 209M+74.0% | 120M+62.5% | 74.1M+26.7% | |
| 505M-17.1% | 609M-9.7% | 675M+19.6% | 564M+20.3% | 469M-39.5% | ||
| Research & development | 239M-9.8% | 265M-2.1% | 270M+1.8% | 266M+25.5% | 212M+71.6% | |
| Selling, general & administrative | 316M-8.2% | 344M+0.3% | 343M+15.1% | 298M+15.8% | 258M+27.3% | |
| Restructuring | 10.6M+3988.8% | 259K-89.6% | 2.48M-41.2% | 4.22M | — | |
| Operating income | -61.0M+68.7% | -195M+26.7% | -265M-58.0% | -168M-221.4% | -52.3M+90.2% | |
| Interest expense | 0.00-100.0% | 4.00K-87.9% | 33.0K-93.1% | 476K-45.0% | 866K-48.5% | |
| Interest & investment income | 20.0M+5.9% | 18.9M+12.1% | 16.9M+154.0% | 6.65M+3126.7% | 206K-86.6% | |
| Other non-operating income | 1.03M+149.8% | -2.07M-622.7% | -286K-44.4% | -198K+75.3% | -802K-160.0% | |
| Pre-tax income | -39.9M+77.5% | -178M+28.6% | -249M-53.6% | -162M-201.5% | -53.7M+89.9% | |
| Income tax | 3.64M-26.2% | 4.93M-22.2% | 6.34M+57.3% | 4.03M-10.6% | 4.51M-45.4% | |
| Net income | -43.5M+76.2% | -183M+28.4% | -255M-53.7% | -166M-185.1% | -58.2M+89.3% | |
| -$0.35+77.0% | -$1.52+30.3% | -$2.18-49.3% | -$1.46-175.5% | -$0.53+90.1% | ||
| EPS (basic) | -$0.35+77.0% | -$1.52+30.3% | -$2.18-49.3% | -$1.46-175.5% | -$0.53+90.1% | |
| Weighted-avg shares (basic) | 125M+3.6% | 120M+2.8% | 117M+2.9% | 114M+3.2% | 110M+9.1% | |
| Weighted-avg shares (diluted) | 125M+3.6% | 120M+2.8% | 117M+2.9% | 114M+3.2% | 110M+9.1% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 684M+17.1% | 584M-2.0% | 596M-6.1% | 635M-15.1% | 748M-3.5% | ||
| Cash & equivalents | 474M+37.8% | 344M-4.2% | 359M+63.5% | 220M-62.6% | 587M-11.5% | |
| Accounts receivable | 47.0M-46.5% | 87.9M-23.5% | 115M+10.2% | 104M+22.2% | 85.3M+66.5% | |
| Inventory | 56.3M-32.2% | 83.1M+12.8% | 73.7M-9.7% | 81.6M+36.1% | 60.0M+100.2% | |
| Prepaid expenses | 22.2M+14.4% | 19.4M+3.3% | 18.8M+13.3% | 16.6M+19.3% | 13.9M+6.7% | |
| 1.04B+13.4% | 919M-4.8% | 965M-6.2% | 1.03B+1.0% | 1.02B+9.6% | ||
| Property, plant & equipment | 227M-10.3% | 253M-9.6% | 280M-3.4% | 289M+70.7% | 169M+132.7% | |
| Operating lease right-of-use | 60.5M+5.5% | 57.3M-12.3% | 65.4M-6.5% | 69.9M+14.7% | 60.9M+29.7% | |
| Goodwill | 4.51M+0.0% | 4.51M+0.0% | 4.51M+0.0% | 4.51M+0.0% | 4.51M | |
| Intangible assets | 62.3M+297.7% | 15.7M-5.7% | 16.6M-27.3% | 22.9M-10.0% | 25.4M+13.6% | |
| Other non-current assets | 2.91M-29.5% | 4.13M+34.8% | 3.06M+28.0% | 2.39M-27.9% | 3.32M-23.2% | |
| 153M+30.5% | 118M-7.5% | 127M-2.9% | 131M+18.7% | 110M-6.6% | ||
| Accounts payable | 12.7M-1.4% | 12.9M-18.0% | 15.7M-27.1% | 21.6M+24.5% | 17.4M+268.5% | |
| Deferred revenue | 23.9M+15.7% | 20.7M+57.1% | 13.2M+67.2% | 7.87M+47.3% | 5.34M+19.4% | |
| Current lease liability | 11.0M+18.3% | 9.29M-19.4% | 11.5M+27.5% | 9.04M+76.1% | 5.13M-13.6% | |
| Other current liabilities | 11.0M+99.5% | 5.51M+24.9% | 4.41M-34.2% | 6.71M-19.0% | 8.29M+41.8% | |
| 245M+17.5% | 209M-7.0% | 224M+0.4% | 223M+10.9% | 201M+5.8% | ||
| Deferred revenue (non-current) | 10.5M-16.1% | 12.5M+42.0% | 8.81M+178.5% | 3.17M | — | |
| Non-current lease liability | 73.4M+0.1% | 73.3M-12.5% | 83.8M-2.7% | 86.1M+12.1% | 76.8M+34.7% | |
| Operating lease liability (total) | 84.4M+2.1% | 82.6M-13.4% | 95.4M+0.2% | 95.2M+16.1% | 82.0M+30.2% | |
| Other non-current liabilities | 6.47M+28.7% | 5.03M+17.6% | 4.28M+43.6% | 2.98M-63.9% | 8.24M+109.7% | |
| 796M+12.1% | 710M-4.2% | 741M-8.0% | 806M-1.4% | 818M+10.6% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 2.00K+0.0% | 2.00K+0.0% | 2.00K+0.0% | 2.00K+0.0% | 2.00K+0.0% | |
| Additional paid-in capital | 2.31B+5.9% | 2.18B+7.5% | 2.03B+10.1% | 1.84B+9.4% | 1.68B+8.8% | |
| Retained earnings | -1.51B-3.0% | -1.47B-14.2% | -1.28B-24.8% | -1.03B-19.2% | -863M-7.2% | |
| Accumulated other comprehensive income | 225K+145.6% | -493K-14.9% | -429K+90.1% | -4.33M-19804.5% | 22.0K+144.0% | |
| Total liabilities & equity | 1.04B+13.4% | 919M-4.8% | 965M-6.2% | 1.03B+1.0% | 1.02B+9.6% | |
| Common shares issued | 128M+4.4% | 122M+2.7% | 119M+3.4% | 115M+2.4% | 113M+3.7% | |
| Common shares outstanding | 128M+4.4% | 122M+2.7% | 119M+3.4% | 115M+2.4% | 113M+3.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 136M+1941.6% | 6.66M+143.9% | -15.2M+54.8% | -33.6M-57.2% | -21.4M+90.2% | ||
| Depreciation & amortization | 36.2M+0.9% | 35.9M+1.0% | 35.5M+40.0% | 25.4M+20.1% | 21.1M+50.7% | |
| Share-based compensation | 109M-22.5% | 141M-15.7% | 167M+22.0% | 137M+42.6% | 96.0M+97.3% | |
| Deferred income taxes | -310K-143.7% | 709K+258.6% | -447K-428.7% | 136K+119.7% | -690K-941.5% | |
| Change in receivables | -41.3M-53.3% | -27.0M-353.9% | 10.6M-44.0% | 18.9M-44.3% | 34.0M+90.7% | |
| Change in inventory | -28.0M-385.9% | 9.78M+224.2% | -7.87M-137.1% | 21.2M-29.7% | 30.1M+106.4% | |
| Change in payables | -2.13M+36.6% | -3.35M+44.3% | -6.02M-202.7% | 5.86M-47.1% | 11.1M+242.7% | |
| Other operating activities | -1.75M-435.2% | 523K+22.5% | 427K-78.2% | 1.96M+2377.2% | 79.0K | |
| -13.4M+58.8% | -32.6M-124.4% | 133M+138.0% | -351M-228.8% | -107M-178.0% | ||
| Capital expenditure | 5.93M-52.1% | 12.4M-74.5% | 48.6M-63.1% | 132M+30.0% | 101M+176.2% | |
| Free cash flow | 130M+2371.2% | -5.73M+91.0% | -63.8M+61.4% | -165M-34.7% | -123M+51.8% | |
| Acquisitions | 0.00 | 0.00 | 0.00-100.0% | 4.00M-26.6% | 5.45M | |
| Sales/maturities of investments | 125M+385.6% | 25.8M-68.9% | 82.8M+347.0% | 18.5M | 0.00 | |
| 6.80M-37.7% | 10.9M-20.2% | 13.7M-13.6% | 15.8M-55.2% | 35.3M-92.5% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 484K+395.1% | -164K-397.0% | -33.0K+25.0% | -44.0K-118.8% | 234K+150.5% | |
| Net change in cash | 130M+953.6% | -15.2M-111.5% | 132M+135.8% | -369M-298.3% | -92.6M-143.6% | |
| Interest paid | 0.00 | 0.00-100.0% | 436K-48.2% | 841K-31.2% | 1.22M-26.8% | |
| Income taxes paid | 2.39M-57.6% | 5.64M+14.5% | 4.93M+25.5% | 3.92M-54.7% | 8.66M+2992.9% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.08B+18.6% | 1.76B-73.3% | 6.59B+58.4% | 4.16B-75.2% | 16.8B+9.1% | |
| P/S | 3.2×+12.7% | 2.9×-74.2% | 11.1×+35.0% | 8.3×-75.8% | 34.2×-33.5% | |
| P/B | 2.6×+5.8% | 2.5×-72.0% | 8.8×+64.9% | 5.4×-73.9% | 20.5×-1.4% | |
| P/FCF | 16.0× | — | — | — | — | |
| FCF yield | 6.2% | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: TXG’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TXG filings on SEC EDGAR → Not investment advice.